Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Other financing activities: 2018-2022

Historic Other financing activities for Puma Biotechnology (PBYI) over the last 1 years, with Dec 2022 value amounting to $69,000.

  • Puma Biotechnology's Other financing activities was N/A to $69,000 in Q4 2022 from the same period last year, while for Dec 2022 it was $2.2 million, marking a year-over-year change of. This contributed to the annual value of $277,000 for FY2022, which is 85.50% down from last year.
  • Puma Biotechnology's Other financing activities amounted to $69,000 in Q4 2022, which was up 30.19% from $53,000 recorded in Q3 2022.
  • In the past 5 years, Puma Biotechnology's Other financing activities ranged from a high of $1.9 million in Q3 2021 and a low of $9,000 during Q4 2018.
  • For the 2-year period, Puma Biotechnology's Other financing activities averaged around $546,750, with its median value being $112,000 (2022).
  • Data for Puma Biotechnology's Other financing activities shows a maximum YoY tumbled of 97.23% (in 2022) over the last 5 years.
  • Over the past 3 years, Puma Biotechnology's Other financing activities (Quarterly) stood at $9,000 in 2018, then reached $1.9 million in 2021, then slumped by 97.23% to $69,000 in 2022.
  • Its Other financing activities stands at $69,000 for Q4 2022, versus $53,000 for Q3 2022 and $155,000 for Q1 2022.